Search Results

Quartesian, a multinational Clinical Research Organization serving the biopharmaceutical and medical device industries, announced that they have deployed Medrio’s cloud-based EDC platform for 265 clinical studies world-wide.

Quartesian, a multinational Clinical Research Organization serving the biopharmaceutical and medical device industries, announced a multi-year agreement with a leading portfolio medical technology company.

Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced that it has earned ISO 9001:2015 certification for its quality management system and the ISO/IEC 27001:2013 certification for its systems and processes for managing sensitive company informatio

Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced membership in Veeva’s new partner program to build studies for sponsors, faster, using Veeva Vault EDC.

Quartesian , a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced its 17th consecutive year of increased contract bookings and record revenue for 2019. “Our clinical data-focused solution strategy continues to ga

Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced a new partnership with Amyndas Pharmaceuticals for their Phase 2 clinical study evaluating the efficacy of AMY-101 in COVID-19 patients with acute respiratory distress syndrome (ARDS). ARDS, a

Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced the availability of its suite of clinical trial data pharmacovigilance services.

This addition strengthens Quartesian’s expertise in analytics, statistics and programming and adds significant statistical therapeutic experience.

Quartesian has been a Medidata partner since 2014, with the collaboration facilitating clinical trial breakthroughs for all market segments, from small phase I to large phase III studies.